Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GABRP | O00591 | 2/20 | 0.32 |
| ▸ | GABRD | O14764 | 2/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.32 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.32 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.32 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.32 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.32 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.32 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.32 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.32 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.32 |
| ▸ | GABRE | P78334 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL452931 | 0.98 | TGFBR1 (0.37) | TGFBR1RXFP1TDP1TSHRCYP2D6 | |
| SCHEMBL30176231 | 0.84 | CYP2D6 (0.40) | CYP2D6CYP2C19KDM4EPOLBGABRP | |
| SCHEMBL24369549 | 0.83 | CYP2D6 (0.33) | CYP2D6CYP2C19GABRPGABRDGABRA1 | |
| SCHEMBL9759560 | 0.83 | TGFBR1 (0.38) | TGFBR1RXFP1TDP1ALDH1A1 | |
| SCHEMBL366427 | 0.82 | CYP2D6 (0.52) | TGFBR1RXFP1TDP1TSHRCYP2D6 | |
| SCHEMBL12642676 | 0.80 | TGFBR1 (0.39) | TGFBR1RXFP1TDP1TSHRCYP2D6 | |
| SCHEMBL9289423 | 0.80 | TGFBR1 (0.39) | TGFBR1RXFP1TDP1TSHRCYP2D6 | |
| SCHEMBL16097 | 0.80 | TGFBR1 (0.39) | TGFBR1RXFP1TDP1TSHRCYP2D6 | |
| SCHEMBL10187391 | 0.79 | GFPT1 (0.46) | TGFBR1SLC7A5 | |
| SCHEMBL5722555 | 0.79 | ANPEP (0.44) | TGFBR1RXFP1TDP1TSHRGABRP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 232 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104587484-A | POLYMERIC SYSTEMS FOR THE DELIVERY OF ANTICANCER DRUGS | REXAHN PHARMACEUTICALS INC | 2015-05-06 | — | — | CN | claimed |
| US-20150071872-A1 | POLYMERIC SYSTEMS FOR THE DELIVERY OF ANTICANCER DRUGS | REXAHN PHARMACEUTICALS INC (US) | 2015-03-12 | — | — | US | claimed |
| CN-102686243-B | Polymeric systems for anticancer agent delivery | REXAHN PHARMACEUTICALS INC | 2015-02-18 | — | — | CN | claimed |
| US-8846110-B2 | Polymeric systems for the delivery of anticancer drugs | REXAHN PHARMACEUTICALS, INC. (US) | 2014-09-30 | — | — | US | claimed |
| CN-102686243-A | Polymeric systems for anticancer agent delivery | REXAHN PHARMACEUTICALS INC | 2012-09-19 | — | — | CN | claimed |
| EP-2488207-A2 | POLYMERIC SYSTEMS FOR THE DELIVERY OF ANTICANCER AGENTS | Rexahn Pharmaceuticals, Inc. (US) | 2012-08-22 | — | — | EP | claimed |
| US-8163390-B2 | Radiation-curable compounds | BASF SE (DE) | 2012-04-24 | — | — | US | claimed |
| WO-2011047051-A2 | POLYMERIC SYSTEMS FOR THE DELIVERY OF ANTICANCER AGENTS | REXAHN PHARMACEUTICALS, INC. (US) | 2011-04-21 | — | — | WO | claimed |
| US-20110086111-A1 | POLYMERIC SYSTEMS FOR THE DELIVERY OF ANTICANCER DRUGS | REXAHN PHARMACEUTICALS, INC. (US) | 2011-04-14 | — | — | US | claimed |
| US-20100098950-A1 | RADIATION-CURABLE COMPOUNDS | BASF SE (DE) | 2010-04-22 | — | — | US | claimed |
| EP-1727868-B1 | CER COMPOUNDS USED AS INITIATORS FOR DUAL CURING | BASF SE (DE) | 2008-05-28 | — | — | EP | claimed |
| WO-2008043723-A1 | RADIATION-CURABLE COMPOUNDS | BASF SE (DE) | 2008-04-17 | — | — | WO | claimed |
| WO-2008043722-A1 | RADIATION-CURABLE COMPOUNDS | BASF SE (DE) | 2008-04-17 | — | — | WO | claimed |
| EP-1902082-A1 | COATING MASSES COMPRISING 2,4'-DIISOCYANATODIPHENYLMETHANE | BASF SE (DE) | 2008-03-26 | — | — | EP | claimed |
| WO-2007088126-A2 | COATINGS REPARABLE BY ENERGY DISCHARGE | BASF SE (DE) | 2007-08-09 | — | — | WO | claimed |
| US-20070172668-A1 | Cer compounds used as initiators for dual curing | BASF AKTIENGESELLSCHAFT (DE) | 2007-07-26 | — | — | US | claimed |
| WO-2007000415-A1 | COATING MASSES COMPRISING 2,4'-DIISOCYANATODIPHENYLMETHANE | BASF AKTIENGESELLSCHAFT (DE) | 2007-01-04 | — | — | WO | claimed |
| EP-1727868-A1 | CER COMPOUNDS USED AS INITIATORS FOR DUAL CURING | BASF Aktiengesellschaft (DE) | 2006-12-06 | — | — | EP | claimed |
| WO-2005090489-A1 | CER COMPOUNDS USED AS INITIATORS FOR DUAL CURING | BASF AKTIENGESELLSCHAFT (DE) | 2005-09-29 | — | — | WO | claimed |
| US-5444110-A | A triazine compound and a plasticizer | NIPPON ZEON CO., LTD. (JP) | 1995-08-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086111-A1 | POLYMERIC SYSTEMS FOR THE DELIVERY OF ANTICANCER DRUGS | APEH, LNPEP, CPA3 | TGFBR1 3625/4885RXFP1 4415/4885TDP1 2359/4885 |
| US-20150071872-A1 | POLYMERIC SYSTEMS FOR THE DELIVERY OF ANTICANCER DRUGS | APEH, LNPEP, CPA3 | TGFBR1 3625/4885RXFP1 4415/4885TDP1 2359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.